Qu Y, Rogers J C, Tanada T N, Catterall W A, Scheuer T
Department of Pharmacology, University of Washington, Seattle 98195-7280, USA.
J Gen Physiol. 1996 Nov;108(5):375-9. doi: 10.1085/jgp.108.5.375.
Inactivation of both brain and cardiac Na+ channels is modulated by activation of protein kinase C (PKC) but in different ways. Previous experiments had shown that phosphorylation of serine 1506 in the highly conserved loop connecting homologous domains III and IV (LIII/IV) of the brain Na+ channel alpha subunit is necessary for all effects of PKC. Here we examine the importance of the analogous serine for the different modulation of the rH1 cardiac Na+ channel. Serine 1505 of rH1 was mutated to alanine to prevent its phosphorylation, and the resulting mutant channel was expressed in 1610 cells. Electrophysiological properties of these mutant channels were indistinguishable from those of wild-type (WT) rH1 channels. Activation of PKC with 1-oleoyl-2-acetyl-sn-glycerol (OAG) reduced WT Na+ current by 49.3 +/- 4.2% (P < 0.01) but S1505A mutant current was reduced by only 8.5 +/- 5.4% (P = 0.29) when the holding potential was -94 mV. PKC activation also caused a -17-mV shift in the voltage dependence of steady-state inactivation of the WT channel which was abolished in the mutant. Thus, phosphorylation of serine 1505 is required for both the negative shift in the inactivation curve and the reduction in Na+ current by PKC. Phosphorylation of S1505/1506 has common and divergent effects in brain and cardiac Na+ channels. In both brain and cardiac Na+ channels, phosphorylation of this site by PKC is required for reduction of peak Na+ current. However, phosphorylation of S1506 in brain Na+ channels slows and destabilizes inactivation of the open channel. Phosphorylation of S1505 in cardiac, but not S1506 in brain, Na+ channels causes a negative shift in the inactivation curve, indicating that it stabilizes inactivation from closed states. Since LIII/IV containing S1505/S1506 is completely conserved, interaction of the phosphorylated serine with other regions of the channel must differ in the two channel types.
脑和心脏的钠离子通道失活均受蛋白激酶C(PKC)激活的调节,但方式不同。先前的实验表明,脑钠离子通道α亚基中连接同源结构域III和IV的高度保守环(LIII/IV)中丝氨酸1506的磷酸化对于PKC的所有效应都是必需的。在此,我们研究了类似丝氨酸对rH1心脏钠离子通道不同调节作用的重要性。将rH1的丝氨酸1505突变为丙氨酸以防止其磷酸化,并将所得突变通道在1610细胞中表达。这些突变通道的电生理特性与野生型(WT)rH1通道的电生理特性没有区别。当钳制电位为-94 mV时,用1-油酰基-2-乙酰基-sn-甘油(OAG)激活PKC可使WT钠离子电流降低49.3±4.2%(P<0.01),但S1505A突变体电流仅降低8.5±5.4%(P=0.29)。PKC激活还导致WT通道稳态失活的电压依赖性负移17 mV,而在突变体中这种负移消失。因此,丝氨酸1505的磷酸化对于失活曲线的负移和PKC介导的钠离子电流降低都是必需的。S1505/1506的磷酸化在脑和心脏钠离子通道中具有共同和不同的作用。在脑和心脏钠离子通道中,PKC对该位点的磷酸化都是降低钠离子电流峰值所必需的。然而,脑钠离子通道中S1506的磷酸化会减慢并破坏开放通道的失活。心脏钠离子通道中S1505的磷酸化而非脑钠离子通道中S1506的磷酸化会导致失活曲线负移,这表明它能稳定从关闭状态开始的失活。由于包含S1505/S1506的LIII/IV完全保守,磷酸化丝氨酸与通道其他区域的相互作用在两种通道类型中必定不同。